298 related articles for article (PubMed ID: 31658988)
1. Tau Misfolding Efficiently Propagates between Individual Intact Hippocampal Neurons.
Hallinan GI; Vargas-Caballero M; West J; Deinhardt K
J Neurosci; 2019 Nov; 39(48):9623-9632. PubMed ID: 31658988
[TBL] [Abstract][Full Text] [Related]
2. Minimalistic in vitro systems for investigating tau pathology.
Hallinan GI; Pitera AP; Patel P; West J; Deinhardt K
J Neurosci Methods; 2019 May; 319():69-76. PubMed ID: 30278185
[TBL] [Abstract][Full Text] [Related]
3. Templated misfolding of Tau by prion-like seeding along neuronal connections impairs neuronal network function and associated behavioral outcomes in Tau transgenic mice.
Stancu IC; Vasconcelos B; Ris L; Wang P; Villers A; Peeraer E; Buist A; Terwel D; Baatsen P; Oyelami T; Pierrot N; Casteels C; Bormans G; Kienlen-Campard P; Octave JN; Moechars D; Dewachter I
Acta Neuropathol; 2015 Jun; 129(6):875-94. PubMed ID: 25862635
[TBL] [Abstract][Full Text] [Related]
4. Intracellular degradation of misfolded tau protein induced by geldanamycin is associated with activation of proteasome.
Opattova A; Filipcik P; Cente M; Novak M
J Alzheimers Dis; 2013; 33(2):339-48. PubMed ID: 22936006
[TBL] [Abstract][Full Text] [Related]
5. Co-culture of Murine Neurons Using a Microfluidic Device for The Study of Tau Misfolding Propagation.
Hallinan GI; Lopez DM; Vargas-Caballero M; West J; Deinhardt K
Bio Protoc; 2020 Aug; 10(16):e3718. PubMed ID: 33659382
[TBL] [Abstract][Full Text] [Related]
6. Removing endogenous tau does not prevent tau propagation yet reduces its neurotoxicity.
Wegmann S; Maury EA; Kirk MJ; Saqran L; Roe A; DeVos SL; Nicholls S; Fan Z; Takeda S; Cagsal-Getkin O; William CM; Spires-Jones TL; Pitstick R; Carlson GA; Pooler AM; Hyman BT
EMBO J; 2015 Dec; 34(24):3028-41. PubMed ID: 26538322
[TBL] [Abstract][Full Text] [Related]
7. The role of microglia in processing and spreading of bioactive tau seeds in Alzheimer's disease.
Hopp SC; Lin Y; Oakley D; Roe AD; DeVos SL; Hanlon D; Hyman BT
J Neuroinflammation; 2018 Sep; 15(1):269. PubMed ID: 30227881
[TBL] [Abstract][Full Text] [Related]
8. Propagation of tau pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies.
Lewis J; Dickson DW
Acta Neuropathol; 2016 Jan; 131(1):27-48. PubMed ID: 26576562
[TBL] [Abstract][Full Text] [Related]
9. Studying tau protein propagation and pathology in the mouse brain using adeno-associated viruses.
Wegmann S; Bennett RE; Amaral AS; Hyman BT
Methods Cell Biol; 2017; 141():307-322. PubMed ID: 28882310
[TBL] [Abstract][Full Text] [Related]
10. Continuous Monitoring of Tau-Induced Neurotoxicity in Patient-Derived iPSC-Neurons.
Oakley DH; Klickstein N; Commins C; Chung M; Dujardin S; Bennett RE; Hyman BT; Frosch MP
J Neurosci; 2021 May; 41(19):4335-4348. PubMed ID: 33893219
[TBL] [Abstract][Full Text] [Related]
11. Prion-like Spreading in Tauopathies.
Ayers JI; Giasson BI; Borchelt DR
Biol Psychiatry; 2018 Feb; 83(4):337-346. PubMed ID: 28506438
[TBL] [Abstract][Full Text] [Related]
12. Different tau species lead to heterogeneous tau pathology propagation and misfolding.
Dujardin S; Bégard S; Caillierez R; Lachaud C; Carrier S; Lieger S; Gonzalez JA; Deramecourt V; Déglon N; Maurage CA; Frosch MP; Hyman BT; Colin M; Buée L
Acta Neuropathol Commun; 2018 Nov; 6(1):132. PubMed ID: 30497516
[TBL] [Abstract][Full Text] [Related]
13. Neurodegenerative lesions: seeding and spreading.
Duyckaerts C
Rev Neurol (Paris); 2013 Oct; 169(10):825-33. PubMed ID: 24035591
[TBL] [Abstract][Full Text] [Related]
14. From the prion-like propagation hypothesis to therapeutic strategies of anti-tau immunotherapy.
Colin M; Dujardin S; Schraen-Maschke S; Meno-Tetang G; Duyckaerts C; Courade JP; Buée L
Acta Neuropathol; 2020 Jan; 139(1):3-25. PubMed ID: 31686182
[TBL] [Abstract][Full Text] [Related]
15. Spreading of Tau Protein Does Not Depend on Aggregation Propensity.
Rodrigues S; Anglada-Huguet M; Hochgräfe K; Kaniyappan S; Wegmann S; Mandelkow EM
J Mol Neurosci; 2023 Oct; 73(9-10):693-712. PubMed ID: 37606769
[TBL] [Abstract][Full Text] [Related]
16. Synaptic Contacts Enhance Cell-to-Cell Tau Pathology Propagation.
Calafate S; Buist A; Miskiewicz K; Vijayan V; Daneels G; de Strooper B; de Wit J; Verstreken P; Moechars D
Cell Rep; 2015 May; 11(8):1176-83. PubMed ID: 25981034
[TBL] [Abstract][Full Text] [Related]
17. Alzheimer's disease brain-derived extracellular vesicles spread tau pathology in interneurons.
Ruan Z; Pathak D; Venkatesan Kalavai S; Yoshii-Kitahara A; Muraoka S; Bhatt N; Takamatsu-Yukawa K; Hu J; Wang Y; Hersh S; Ericsson M; Gorantla S; Gendelman HE; Kayed R; Ikezu S; Luebke JI; Ikezu T
Brain; 2021 Feb; 144(1):288-309. PubMed ID: 33246331
[TBL] [Abstract][Full Text] [Related]
18. The Role of Protein Misfolding and Tau Oligomers (TauOs) in Alzheimer's Disease (AD).
Mroczko B; Groblewska M; Litman-Zawadzka A
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31547024
[TBL] [Abstract][Full Text] [Related]
19. GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils.
Gibbons GS; Banks RA; Kim B; Xu H; Changolkar L; Leight SN; Riddle DM; Li C; Gathagan RJ; Brown HJ; Zhang B; Trojanowski JQ; Lee VM
J Neurosci; 2017 Nov; 37(47):11485-11494. PubMed ID: 28986461
[TBL] [Abstract][Full Text] [Related]
20. Fate and propagation of endogenously formed Tau aggregates in neuronal cells.
Chastagner P; Loria F; Vargas JY; Tois J; I Diamond M; Okafo G; Brou C; Zurzolo C
EMBO Mol Med; 2020 Dec; 12(12):e12025. PubMed ID: 33179866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
